UBE2C-Mediated CD147-CTLA-4 Axis Promotes T Cell Exhaustion and Immunosuppressive Microenvironment in Bladder Cancer [0.03%]
UBE2C介导的CD147-CTLA-4轴促进膀胱癌T细胞衰竭和免疫抑制微环境
Xuwei Hong,Ting Hong,Xinyu Liu et al.
Xuwei Hong et al.
Despite immune checkpoint inhibitors (ICIs) having benefited bladder cancer (BCa) patients, their limited response rates urge elucidation of intrinsic resistance mechanisms. In this study, we demonstrated that ubiquitin conjugating enzyme E...
MTAP Deficiency as a Metabolic Vulnerability in Cancer: Implications for Synthetic Lethal Therapy [0.03%]
肿瘤代谢脆弱性MTAP缺陷的合成致死治疗机制研究进展
Hiroaki Ikushima,Hidenori Kage
Hiroaki Ikushima
The homozygous deletion of the chromosome 9p21.3 locus, which includes cyclin-dependent kinase inhibitor 2A/B (CDKN2A/B) and methylthioadenosine phosphorylase (MTAP) genes, is one of the most common genomic alterations in cancer. MTAP encod...
Epithelial YPEL3 Modulates CD8+ T-Cell Infiltration and Tumor Progression Through CREB1-CXCL16 Signaling in HNSCC [0.03%]
头颈鳞癌上皮YPEL3通过CREB1-CXCL16信号调控CD8+T细胞浸润及肿瘤进展
Yalun Li,Yumei Li,Caiyu Sun et al.
Yalun Li et al.
Yippee-like 3 (YPEL3) has been implicated in the regulation of apoptosis, proliferation, and invasion in various cancers, but its role in head and neck squamous cell carcinoma (HNSCC) remains unclear. Here, we integrated pan-cancer data, TC...
Pathophysiological and Molecular Features of DXd ADC-Related Interstitial Pneumonitis in Cynomolgus Monkeys [0.03%]
食蟹猴DXd抗体药物偶联物相关间质性肺炎的病理生理和分子特征研究
Kazuyoshi Kumagai,Takuma Iguchi,Kentaro Kubota et al.
Kazuyoshi Kumagai et al.
Interstitial lung disease (ILD) is an important adverse event related to deruxtecan-based antibody-drug conjugates (DXd ADCs). Understanding mechanisms and translationally relevant preclinical models remain incompletely defined. Here, we es...
MiR-375 in CAFs-Derived EVs Promotes HCC Progression via Regulating RASA1 and May Potentially Serve as a Biomarker for HCC [0.03%]
CAF来源的外泌体中miR-375通过调控RASA1促进肝癌进展且可作为潜在标志物
Wei Qin,Li Wang,Beiyuan Hu et al.
Wei Qin et al.
Cancer-associated fibroblasts (CAFs) in the tumor microenvironment play an important role in cancer initiation and progression through mediating crosstalk between CAFs and cancer cells. In our study, we unveiled that CAFs-derived extracellu...
Mutational Signature-Based Biomarker for Phase II Trial of Olaparib Maintenance in Advanced High-Grade Ovarian Cancer [0.03%]
基于奥拉帕利维持治疗晚期高级别卵巢癌Ⅱ期临床试验的突变特征生物标志物研究
Katsutoshi Oda,Daisuke Shintani,Akira Nishijima et al.
Katsutoshi Oda et al.
We aimed to develop the mutational signature-based BioMarker (MSBM) to define homologous recombination deficiency (HRD) in newly diagnosed, advanced ovarian cancer and overcome limitations of genomic scar-based assays. We conducted a phase ...
Tumor-Derived Extracellular Vesicles in Plasma for Predicting Anti-PD-1 Antibody Efficacy in Non-Small Cell Lung Cancer [0.03%]
血浆中肿瘤来源的外泌体用于预测非小细胞肺癌抗PD-1抗体疗效
Tomonari Kinoshita,Shigeki Ohta,Seiki Wakui et al.
Tomonari Kinoshita et al.
Liquid biopsy is a promising biomarker for cancer detection and prediction of therapy responses. In this study, we developed new antibody-based sandwich assays to measure three extracellular vesicle (EV) subsets that express cell surface vi...
Blocking SETD2 Enhances the Therapeutic Efficiency of Menin Inhibitor in MLL-Fusion Leukemia [0.03%]
SETD2抑制能增强menin抑制剂在MLL融合白血病治疗中的效率
Anpei Li,Yuan Zhang,Ziwei Li et al.
Anpei Li et al.
During transcriptional elongation, the histone methyltransferase SETD2 binds to RNA polymerase II and deposits trimethylation marks at histone H3 lysine 36 (H3K36me3). However, the role of SETD2 in MLL-fusion leukemia has remained controver...
The Natural Quassinoid Brusatol Enhances Venetoclax Efficacy and Overcomes Resistance in Myeloid Leukemias [0.03%]
天然奎松素brusatol可增强ABT-199(维奈克拉)疗效并克服髓系白血病耐药性
Shin-Ichiro Kawaguchi,Kazuya Sato,Junko Izawa et al.
Shin-Ichiro Kawaguchi et al.
While venetoclax-based combinations have shown promising results in acute myeloid leukemia (AML), the remission duration is generally short, warranting strategies to further improve efficacy and overcome resistance. Here, we show that the n...
A cDC1-NK/T-Malignant Cell Circuit Drives Immunogenic Remodeling Under PD-1 Blockade in Gastric Cancer [0.03%]
胃癌中PD-1阻断下的免疫重塑由cDC1- NK/T-恶性细胞电路驱动
Takuya Nakatsuru,Hiroki Yamashita,Chiaki Mashima et al.
Takuya Nakatsuru et al.
The gastric cancer (GC) tumor microenvironment (TME) constitutes a complex and dynamic ecosystem in which immune, stromal, and malignant cells (MCs) collectively shape therapeutic responses. The dynamics of GC TME remodeling in different tr...